U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...

Mature overall survival results of the INAVO120 trial were presented in a press conference for the American Society of ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

Pfizer's (NYSE: PFE) management team is confident in its 2025 opportunities. Where to invest $1,000 right now? Our analyst ...

Astellas Pharma (ALPMY) and Pfizer (PFE) announced longer-term follow-up results from an open-label extension of the Phase 3 ...

Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...

The US Food and Drug Administration has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines.

The U.S. has detected the NB.1.8.1 COVID-19 variant, dominant in China, through airport screenings and health departments ...

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

Government advisers debate updating COVID-19 vaccines for next season amid confusion over new U.S. policy on booster shots.